Please use this identifier to cite or link to this item:
https://hdl.handle.net/10316/24816
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Duarte, Sónia | - |
dc.contributor.author | Carle, Georges | - |
dc.contributor.author | Faneca, Henrique | - |
dc.contributor.author | Lima, Maria C. Pedroso de | - |
dc.contributor.author | Pierrefite-Carle, Valérie | - |
dc.date.accessioned | 2013-12-27T16:44:58Z | - |
dc.date.available | 2013-12-27T16:44:58Z | - |
dc.date.issued | 2012-11 | - |
dc.identifier.citation | DUARTE, Sónia [et al.] - Suicide gene therapy in cancer: Where do we stand now?. "Cancer Letters". ISSN 0304-3835. 324:2 (2012) 160-170 | por |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | https://hdl.handle.net/10316/24816 | - |
dc.description.abstract | Suicide gene therapy is based on the introduction into tumor cells of a viral or a bacterial gene, which allows the conversion of a non-toxic compound into a lethal drug. Although suicide gene therapy has been successfully used in a large number of in vitro and in vivo studies, its application to cancer patients has not reached the desirable clinical significance. However, recent reports on pre-clinical cancer models demonstrate the huge potential of this strategy when used in combination with new therapeutic approaches. In this review, we summarize the different suicide gene systems and gene delivery vectors addressed to cancer, with particular emphasis on recently developed systems and associated bystander effects. In addition, we review the different strategies that have been used in combination with suicide gene therapy and provide some insights into the future directions of this approach, particularly towards cancer stem cell eradication. | por |
dc.language.iso | eng | por |
dc.publisher | Elsevier | por |
dc.rights | openAccess | por |
dc.subject | Suicide gene therapy | por |
dc.subject | Cancer | por |
dc.subject | Bystander effect | por |
dc.subject | Combined strategies | por |
dc.title | Suicide gene therapy in cancer: Where do we stand now? | por |
dc.type | article | por |
degois.publication.firstPage | 160 | por |
degois.publication.lastPage | 170 | por |
degois.publication.issue | 2 | por |
degois.publication.title | Cancer Letters | por |
dc.relation.publisherversion | http://www.sciencedirect.com/science/journal/03043835 | por |
dc.peerreviewed | Yes | por |
dc.identifier.doi | 10.1016/j.canlet.2012.05.023 | - |
degois.publication.volume | 324 | por |
item.fulltext | Com Texto completo | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.openairetype | article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | open | - |
crisitem.author.researchunit | CNC - Center for Neuroscience and Cell Biology | - |
crisitem.author.orcid | 0000-0003-1844-5027 | - |
Appears in Collections: | I&D CNC - Artigos em Revistas Internacionais FCTUC Ciências da Vida - Artigos em Revistas Internacionais |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Suicide gene therapy in cancer.pdf | 584.86 kB | Adobe PDF | View/Open |
SCOPUSTM
Citations
172
checked on Oct 7, 2024
WEB OF SCIENCETM
Citations
1
155
checked on Oct 2, 2024
Page view(s) 10
1,007
checked on Oct 15, 2024
Download(s) 50
1,187
checked on Oct 15, 2024
Google ScholarTM
Check
Altmetric
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.